Assessment of anxiety and depression and selected psychosocial variables in cancer patients.

Objectives: Assessment of anxiety-depressive disorders in an oncologically ill patient may help in the treatment process and planning psycho-oncological care. The aim of the study was to assess the level of anxiety and depression and selected psychosocial variables in cancer patients.

Methods: The study group consisted of cancer patients eligible for causal treatment for at least 6 weeks.

Anxiety and depression and cognitive coping strategies and health locus of control in patients with ovary and uterus cancer during anticancer therapy.

Aim Of The Study: The crisis associated with cancer may contribute to the development of anxiety and depressive disorders. Contemporary psycho-oncology focuses on the psychological determinants of the cancer patients functioning to find which disease-coping strategies help the healing process, facilitate the establishment of a good therapeutic relationship and the process of adapting to difficult situations. Aim of the study was assess the psychological functioning of patients with cancer of reproductive organs in the cancer-treating process.

Anxiety and depression, cognitive coping strategies, and health locus of control in patients with digestive system cancer.

Introduction: Contemporary psycho-oncology focuses on the study of the psychological determinants of the functioning of cancer patients. Among the psychological factors that significantly affect the functioning of the patients are anxiety and depressive disorders.

Aim: To assess the psychological functioning of patients with digestive system cancer in the cancer-treating process and to develop guidelines for psychological care dedicated to this group of patients based on the results of the study.

Efficacy and tolerability of diclofenac potassium sachets in acute postoperative dental pain: a placebo-controlled, randomised, comparative study vs. diclofenac potassium tablets.

This double-blind, randomised, parallel-group trial compared the analgesic efficacy of single 50 mg doses of diclofenac potassium sachets and tablets with placebo in 184 patients with moderate/severe pain after third molar extraction. The primary efficacy variable was the average pain reduction from baseline during the first 2-h postdose, using a visual analogue scale (VAS). During the first 2-h postdose, sachets and tablets significantly reduced pain (p < 0.